Your browser doesn't support javascript.
loading
Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer.
Oosting, Linette T; Franke, Katka; Martin, Michael V; Kloosterman, Wigard P; Jamieson, Jennifer A; Glenn, Laura A; de Jager, Miranda W; van Zanten, Jacoba; Allersma, Derk P; Gareb, Bahez.
Afiliação
  • Oosting LT; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Franke K; CureVac Netherlands B.V., Matrix Building VII, Science Park 106, 1098 XG Amsterdam, The Netherlands.
  • Martin MV; CureVac Netherlands B.V., Matrix Building VII, Science Park 106, 1098 XG Amsterdam, The Netherlands.
  • Kloosterman WP; CureVac Netherlands B.V., Matrix Building VII, Science Park 106, 1098 XG Amsterdam, The Netherlands.
  • Jamieson JA; Almac Sciences Scotland Ltd., The Fleming Building, Edinburgh Technopole, Milton Bridge, Penicuik EH26 0BE, UK.
  • Glenn LA; Almac Sciences Scotland Ltd., The Fleming Building, Edinburgh Technopole, Milton Bridge, Penicuik EH26 0BE, UK.
  • de Jager MW; 3D-PharmXchange, Maidstone 48a, 5026 SK Tilburg, The Netherlands.
  • van Zanten J; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Allersma DP; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
  • Gareb B; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Pharmaceutics ; 14(7)2022 Jul 21.
Article em En | MEDLINE | ID: mdl-35890409

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Pharmaceutics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Pharmaceutics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda